Showing results (331-340 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|February 17, 2001
Effects of enzyme inducers and inhibitor on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in ratsS Bu, Y Kim, S Kim, et al.Biopharmaceutics & Drug Disposition|February 17, 2001
Bioequivalence evaluation of norfloxacin 400 mg tablets (Uroxin and Noroxin) in healthy human volunteersK Al-Rashood, K Al-Khamis, Y El-Sayed, et al.Biopharmaceutics & Drug Disposition|November 7, 2019
WB-PBPK approach in predicting zidovudine pharmacokinetics in preterm neonatesLiuya Wei, Najia Mansoor, Rafeeq Alam Khan, et al.Biopharmaceutics & Drug Disposition|March 20, 2020
Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonistRenata Murgasova, Ester Tor Carreras, Martina Suetterlin-Hachmann, et al.Biopharmaceutics & Drug Disposition|February 12, 2020
Increased membrane permeation and blood concentration of 6-carboxyfluorescein associated with dysfunction of paracellular route barrier in the small intestine of ulcerative colitis model ratsMaho Kumagai, Makoto Ishii, Kaori Morimoto, et al.Biopharmaceutics & Drug Disposition|January 17, 2020
Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to ratsDaifei Wang, Weibang Yu, Lin Cao, et al.Biopharmaceutics & Drug Disposition|December 6, 2018
Pharmacokinetics and metabolism of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator, in rats and monkeysShin-Ichiro Ogawa, Yoshihiko Tsunenari, Hiroyuki Kawai, et al.Biopharmaceutics & Drug Disposition|April 5, 2020
Cytochrome P450 expression patterns in human osteoblasts during osteogenic differentiation with or without TNFα treatmentJanak L Pathak, Lingyu Liu, Yong-Qiang Zhu, et al.Biopharmaceutics & Drug Disposition|April 15, 2004
Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrateHyun J Shim, Yu C Kim, Eun J Kim, et al.Biopharmaceutics & Drug Disposition|June 21, 2005
Pharmacokinetics of repinotan in healthy and brain injured animalsThomas Schwarz, Bernhard Beckermann, Klaus Buehner, et al.Pageof 214